Skip to main navigation Skip to search Skip to main content

An incremental effectiveness analysis of palbociclib for the treatment of Hr-positive, Her2-negative locally advanced or metastatic breast cancer in Portugal

  • B. Pinheiro*
  • , A. T. Paquete
  • , R. Sousa
  • , M. Inês
  • , M. Gouveia
  • , M. Borges
  • *Corresponding author for this work

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberPDG68
Pages (from-to)S530-S530
Number of pages1
JournalValue in Health
Volume23
Issue numberSuppl 2
Publication statusPublished - Dec 2020
EventVirtual ISPOR Europe 2020 -
Duration: 16 Nov 202019 Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this